In silico design of novel CDK2 inhibitors through QSAR, ADMET, molecular docking and molecular dynamics simulation studies

References

• Advanced Chemistry Development. (2016). ACD/ChemSketch Freeware. Advanced chemistry development, Inc., Toronto, ON, Canada. http://www.acdlabs.com.
   Google Scholar
• Al-Khafaji, K., & Taskin Tok, T. (2020). Molecular dynamics simulation, free energy landscape and binding free energy computations in exploration the anti-invasive activity of amygdalin against metastasis. Computer Methods and Programs in Biomedicine, 195, 105660. https://doi.org/10.1016/j.cmpb.2020.105660
   PubMed Web of Science ®Google Scholar
• Allouche, A. (2011). Software news and updates Gabedit—A graphical user interface for computational chemistry softwares. Journal of Computational Chemistry, 32(1), 174–182. https://doi.org/10.1002/jcc
   PubMed Web of Science ®Google Scholar
• Altekruse, S. F., McGlynn, K. A., & Reichman, M. E. (2009). Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 27(9), 1485–1491. https://doi.org/10.1200/JCO.2008.20.7753
   PubMed Web of Science ®Google Scholar
• Ayati, A., Emami, S., Asadipour, A., Shafiee, A., & Foroumadi, A. (2015). Recent applications of 1,3-thiazole core structure in the identification of new lead compounds and drug discovery. European Journal of Medicinal Chemistry, 97, 699–718. https://doi.org/10.1016/j.ejmech.2015.04.015
   PubMed Web of Science ®Google Scholar
• Ballard, P., Brassil, P., Bui, K. H., Dolgos, H., Petersson, C., Tunek, A., & Webborn, P. J. H. (2012). The right compound in the right assay at the right time: An integrated discovery DMPK strategy. Drug Metabolism Reviews, 44(3), 224–252. https://doi.org/10.3109/03602532.2012.691099
   PubMed Web of Science ®Google Scholar
• Belhassan, A., Chtita, S., Lakhlifi, T., & Bouachrine, M. (2017). QSPR study of the retention/release property of odorant molecules in water using statistical methods. Orbital, 9, 234–247. https://doi.org/10.17807/orbital.v9i4.978
   Google Scholar
• Borcea, A. M., Ionuț, I., Crișan, O., & Oniga, O. (2021). An overview of the synthesis and antimicrobial, antiprotozoal, and antitumor activity of thiazole and bisthiazole derivatives. Molecules, 26(3), 624. https://doi.org/10.3390/molecules26030624
   PubMed Web of Science ®Google Scholar
• Chang, S., Zhang, Z., Zhuang, X., Luo, J., Cao, X., Li, H., Tu, Z., Lu, X., Ren, X., & Ding, K. (2012). New thiazole carboxamides as potent inhibitors of Akt kinases. Bioorganic & Medicinal Chemistry Letters, 22(2), 1208–1212. https://doi.org/10.1016/j.bmcl.2011.11.080
   PubMed Web of Science ®Google Scholar
• ChemOffice. (2020). PerkinElmer Informatics 2020. http://www.cambridgesoft.com.
   Google Scholar
• Chtita, S., Aouidate, A., Belhassan, A., Ousaa, A., Taourati, A. I., Elidrissi, B., Ghamali, M., Bouachrine, M., & Lakhlifi, T. (2020). QSAR study of N -substituted oseltamivir derivatives as potent avian influenza virus H5N1 inhibitors using quantum chemical descriptors and statistical methods. New Journal of Chemistry, 44(5), 1747–1760. https://doi.org/10.1039/C9NJ04909F
   Web of Science ®Google Scholar
• Chtita, S., Belhassan, A., Bakhouch, M., Taourati, A. I., Aouidate, A., Belaidi, S., Moutaabbid, M., Belaaouad, S., Bouachrine, M., & Lakhlifi, T. (2021). QSAR study of unsymmetrical aromatic disulfides as potent avian SARS-CoV main protease inhibitors using quantum chemical descriptors and statistical methods. Chemometrics and Intelligent Laboratory Systems : An International Journal Sponsored by the Chemometrics Society, 210, 104266. https://doi.org/10.1016/j.chemolab.2021.104266
   PubMed Web of Science ®Google Scholar
• Daina, A., Michielin, O., & Zoete, V. (2017). SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific Reports, 7, 42717. https://doi.org/10.1038/srep42717
   PubMed Web of Science ®Google Scholar
• Darabi, H. R., Aghapoor, K., Balavar, Y., Mobedi, E., Farhangian, H., & Mohsenzadeh, F. (2008). Synthesis of 1,n-acyloxy thioamides by the Willgerodt-Kindler reaction: Chemoselectivity of 1,3-ketoesters over 1,3-diketones. Zeitschrift Für Naturforschung B, 63(8), 993–997. https://doi.org/10.1515/ZNB-2008-0812/MACHINEREADABLECITATION/RIS
   Google Scholar
• Das, D., Sikdar, P., & Bairagi, M. (2016). Recent developments of 2-aminothiazoles in medicinal chemistry. European Journal of Medicinal Chemistry, 109, 89–98. https://doi.org/10.1016/j.ejmech.2015.12.022
   PubMed Web of Science ®Google Scholar
• De Azevedo, W. F., Leclerc, S., Meijer, L., Havlicek, L., Strnad, M., & Kim, S. H. (1997). Inhibition of cyclin-dependent kinases by purine analogues. Crystal structure of human cdk2 complexed with roscovitine. European Journal of Biochemistry, 243(1-2), 518–526. https://doi.org/10.1111/j.1432-1033.1997.0518a.x
   PubMedGoogle Scholar
• Deng, R., Yang, F., Chang, S. H., Tang, J., Qin, J., Feng, G. K., Ding, K., & Zhu, X. F. (2012). DC120, a novel and potent inhibitor of AKT kinase, induces tumor cell apoptosis and suppresses tumor growth. Molecular Pharmacology, 82(2), 189–198. https://doi.org/10.1124/mol.111.077271
   PubMed Web of Science ®Google Scholar
• Dennington, R., Keith, T. A., & Millam, J. M. (2016). GaussView., Version 6.0. 16. Semichem Inc.
   Google Scholar
• Dey, D., Biswas, P., Paul, P., Mahmud, S., Ema, T. I., Khan, A. A., Ahmed, S. Z., Hasan, M. M., Saim, A., Saikat, M., Fatema, B., Bibi, S., Rahman, A., & Kim, B. (2022). Natural flavonoids effectively block the CD81 receptor of hepatocytes and inhibit HCV infection : a computational drug development approach. Molecular Diversity, https://doi.org/10.1007/s11030-022-10491-9
   Web of Science ®Google Scholar
• Domínguez-Villa, F. X., Durán-Iturbide, N. A., & Ávila-Zárraga, J. G. (2021). Synthesis, molecular docking, and in silico ADME/Tox profiling studies of new 1-aryl-5-(3-azidopropyl)indol-4-ones: Potential inhibitors of SARS CoV-2 main protease. Bioorganic Chemistry, 106, 104497. https://doi.org/10.1016/j.bioorg.2020.104497
   PubMed Web of Science ®Google Scholar
• Egan, W. J., Merz, K. M., & Baldwin, J. J. (2000). Prediction of drug absorption using multivariate statistics. Journal of Medicinal Chemistry, 43(21), 3867–3877. https://doi.org/10.1021/jm000292e
   PubMed Web of Science ®Google Scholar
• El-Naggar, A. M., Eissa, I. H., Belal, A., & El-Sayed, A. A. (2020). Design, eco-friendly synthesis, molecular modeling and anticancer evaluation of thiazol-5(4: H)-ones as potential tubulin polymerization inhibitors targeting the colchicine binding site. RSC Advances, 10(5), 2791–2811. https://doi.org/10.1039/c9ra10094f
   PubMed Web of Science ®Google Scholar
• El-Naggar, A. M., El-Hashash, M. A., & Elkaeed, E. B. (2021). Eco-friendly sequential one-pot synthesis, molecular docking, and anticancer evaluation of arylidene-hydrazinyl-thiazole derivatives as CDK2 inhibitors. Bioorganic Chemistry, 108, 104615. https://doi.org/10.1016/j.bioorg.2020.104615
   PubMed Web of Science ®Google Scholar
• El-Naggar, A. M., Zidan, A., Elkaeed, E. B., Taghour, M. S., & Badawi, W. A. (2022). Design, synthesis and docking studies of new hydrazinyl-thiazole derivatives as anticancer and antimicrobial agents. Journal of Saudi Chemical Society, 26(4), 101488. https://doi.org/10.1016/j.jscs.2022.101488
   Web of Science ®Google Scholar
• Eriksson, L., Jaworska, J., Worth, A. P., Cronin, M. T. D., McDowell, R. M., & Gramatica, P. (2003). Methods for reliability and uncertainty assessment and for applicability evaluations of classification- and regression-based QSARs. Environmental Health Perspectives, 111(10), 1361–1375. https://doi.org/10.1289/ehp.5758
   PubMed Web of Science ®Google Scholar
• Estève, E., Bazin, D., Jouanneau, C., Rouzière, S., Bataille, A., Kellum, A., Provost, K., Mocuta, C., Reguer, S., Thiaudière, D., Jorissen, K., Rehr, J. J., Hertig, A., Rondeau, É., Letavernier, E., Daudon, M., & Ronco, P. (2016). How to assess the role of Pt and Zn in the nephrotoxicity of Pt anti-cancer drugs? An investigation combining μXRF and statistical analysis: Part I: On mice. Comptes Rendus Chim, 19(11–12), 1580–1585. https://doi.org/10.1016/j.crci.2016.03.014
   Web of Science ®Google Scholar
• Freire, E. (2009). A thermodynamic approach to the affinity optimization of drug candidates. Chemical Biology & Drug Design, 74(5), 468–472. https://doi.org/10.1111/j.1747-0285.2009.00880.x
   PubMed Web of Science ®Google Scholar
• Frisch, M. J., Trucks, G. W., Schlegel, H. B., Scuseria, G. E., Robb, M. A., Cheeseman, J. R., Scalmani, G., Barone, V., Mennucci, B., Petersson, G. A., Nakatsuji, H., Caricato, M., Li, X., Hratchian, H. P., Izmaylov, A. F., Bloino, J., Zheng, G., Sonnenberg, J. L., Hada, M., … Cioslowski, D. J. (2009). Fox. Gaussian 09, Revision B.01. Gaussian, Inc.
   Google Scholar
• Gabrielsson, J., Dolgos, H., Gillberg, P. G., Bredberg, U., Benthem, B., & Duker, G. (2009). Early integration of pharmacokinetic and dynamic reasoning is essential for optimal development of lead compounds: Strategic considerations. Drug Discovery Today, 14(7–8), 358–372. https://doi.org/10.1016/j.drudis.2008.12.011
   PubMed Web of Science ®Google Scholar
• Geierhaas, C. D., Nickson, A. A., Lindorff-Larsen, K., Clarke, J., & Vendruscolo, M. (2007). BPPred: A Web-based computational tool for predicting biophysical parameters of proteins. Protein Science : A Publication of the Protein Society, 16(1), 125–134. https://doi.org/10.1110/ps.062383807
   PubMed Web of Science ®Google Scholar
• George Priya Doss, C., & Nagasundaram, N. (2014). Molecular docking and molecular dynamics study on the effect of ERCC1 deleterious polymorphisms in ERCC1-XPF heterodimer. Applied Biochemistry and Biotechnology, 172(3), 1265–1281. https://doi.org/10.1007/s12010-013-0592-5
   PubMed Web of Science ®Google Scholar
• Gillis, E. P., Eastman, K. J., Hill, M. D., Donnelly, D. J., & Meanwell, N. A. (2015). Applications of fluorine in medicinal chemistry. Journal of Medicinal Chemistry, 58(21), 8315–8359. https://doi.org/10.1021/acs.jmedchem.5b00258
   PubMed Web of Science ®Google Scholar
• Gramatica, P. (2007). Principles of QSAR models validation: Internal and external. QSAR & Combinatorial Science, 26(5), 694–701. https://doi.org/10.1002/qsar.200610151
   Google Scholar
• Gumbart, J., Khalili-Araghi, F., Sotomayor, M., & Roux, B. (2012). Constant electric field simulations of the membrane potential illustrated with simple systems. Biochimica et Biophysica Acta, 1818(2), 294–302. https://doi.org/10.1016/j.bbamem.2011.09.030
   PubMed Web of Science ®Google Scholar
• Hadaji, E., Bouachrine, M., Hamdani, H. E., & Ouammou, A. (2020). QSAR and molecular docking study of quinolin derivatives with topoisomerase I inhibitory properties as potential anticancer agents using statistical methods. Materials Today: Proceedings, https://doi.org/10.1016/j.matpr.2020.08.032
   Google Scholar
• Hadni, H., & Elhallaoui, M. (2020). 2D and 3D-QSAR, molecular docking and ADMET properties: In silico studies of azaaurones as antimalarial agents. New Journal of Chemistry, 44(16), 6553–6565. https://doi.org/10.1039/C9NJ05767F
   Web of Science ®Google Scholar
• Han, Y., Zhang, J., Hu, C. Q., Zhang, X., Ma, B., & Zhang, P. (2019). In silico ADME and toxicity prediction of ceftazidime and its impurities. Frontiers in Pharmacology, 10, 434. https://doi.org/10.3389/fphar.2019.00434
   PubMed Web of Science ®Google Scholar
• Hann, M. M. (2011). Molecular obesity, potency and other addictions in drug discovery. MedChemComm, 2(5), 349–355. https://doi.org/10.1039/C1MD00017A
   Web of Science ®Google Scholar
• Hansch, C., Leo, A., Mekapati, S. B., & Kurup, A. (2004). QSAR and ADME. Bioorganic & Medicinal Chemistry, 12(12), 3391–3400. https://doi.org/10.1016/j.bmc.2003.11.037
   PubMed Web of Science ®Google Scholar
• Hariharan, P. C., & Pople, J. A. (1973). The influence of polarization functions on molecular orbital hydrogenation energies. Theoretica Chimica Acta, 28(3), 213–222. https://doi.org/10.1007/BF00533485
   Google Scholar
• Heimbach, J. K., Kulik, L. M., Finn, R. S., Sirlin, C. B., Abecassis, M. M., Roberts, L. R., Zhu, A. X., Murad, M. H., & Marrero, J. A. (2018). AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology (Baltimore, Md.), 67(1), 358–380. https://doi.org/10.1002/hep.29086
   PubMed Web of Science ®Google Scholar
• Hess, B., Bekker, H., Berendsen, H. J. C., & Fraaije, J. G. E. M. (1997). LINCS: A Linear Constraint Solver for molecular simulations. Journal of Computational Chemistry, 18(12), 1463–1472. https://doi.org/10.1002/(SICI)1096-987X(199709)18:12 < 1463::AID-JCC4 > 3.0.CO;2-H
   Web of Science ®Google Scholar
• Hill, A. P., & Young, R. J. (2010). Getting physical in drug discovery: A contemporary perspective on solubility and hydrophobicity, Drug. Drug Discovery Today. 15(15–16), 648–655. https://doi.org/10.1016/j.drudis.2010.05.016
   PubMed Web of Science ®Google Scholar
• Holohan, C., Van Schaeybroeck, S., Longley, D. B., & Johnston, P. G. (2013). Cancer drug resistance: An evolving paradigm. Nature Reviews. Cancer, 13(10), 714–726. https://doi.org/10.1038/nrc3599
   PubMed Web of Science ®Google Scholar
• Islam, R., Parves, M. R., Paul, A. S., Uddin, N., Rahman, M. S., Mamun, A. A., Hossain, M. N., Ali, M. A., & Halim, M. A. (2021). A molecular modeling approach to identify effective antiviral phytochemicals against the main protease of SARS-CoV-2. Journal of Biomolecular Structure & Dynamics, 39(9), 3213–3224. https://doi.org/10.1080/07391102.2020.1761883
   PubMed Web of Science ®Google Scholar
• Jin, Z., Wang, Y., Yu, X. F., Tan, Q. Q., Liang, S. S., Li, T., Zhang, H., Shaw, P. C., Wang, J., & Hu, C. (2020). Structure-based virtual screening of influenza virus RNA polymerase inhibitors from natural compounds: Molecular dynamics simulation and MM-GBSA calculation. Computational Biology and Chemistry, 85, 107241. https://doi.org/10.1016/j.compbiolchem.2020.107241
   PubMed Web of Science ®Google Scholar
• Johnson, T. W., Dress, K. R., & Edwards, M. (2009). Using the golden triangle to optimize clearance and oral absorption. Bioorganic & Medicinal Chemistry Letters, 19(19), 5560–5564. https://doi.org/10.1016/j.bmcl.2009.08.045
   PubMed Web of Science ®Google Scholar
• Kalantzi, L., Goumas, K., Kalioras, V., Abrahamsson, B., Dressman, J. B., & Reppas, C. (2006). Characterization of the human upper gastrointestinal contents under conditions simulating bioavailability/bioequivalence studies. Pharmaceutical Research, 23(1), 165–176. https://doi.org/10.1007/s11095-005-8476-1
   PubMed Web of Science ®Google Scholar
• Khaldan, A., Bouamrane, S., El-Mernissi, R., Maghat, H., Ajana, M. A., Sbai, A., Bouachrine, M., & Lakhlifi, T. (2022). In silico design of new α-glucosidase inhibitors through 3D-QSAR study, molecular docking modeling and ADMET analysis. Moroccan Journal of Chemistry, 10, 022–036. https://doi.org/10.48317/IMIST.PRSM/morjchem-v10i1.31722
   Web of Science ®Google Scholar
• Khaldan, A., Bouamrane, S., El-Mernissi, R., Maghat, H., Ajana, M. A., Sbai, A., Bouachrine, M., & Lakhlifi, T. (2021). 3D-QSAR modeling, molecular docking and ADMET properties of benzothiazole derivatives as a-glucosidase inhibitors. Materials Today Proceedings, 45, 7643–7652. https://doi.org/10.1016/j.matpr.2021.03.114
   Google Scholar
• Khan, S. A., Zia, K., Ashraf, S., Uddin, R., & Ul-Haq, Z. (2021). Identification of chymotrypsin-like protease inhibitors of SARS-CoV-2 via integrated computational approach. Journal of Biomolecular Structure & Dynamics, 39(7), 2607–2616. https://doi.org/10.1080/07391102.2020.1751298
   PubMed Web of Science ®Google Scholar
• Kiralj, R., & Ferreira, M. M. C. (2009). Basic validation procedures for regression models in QSAR and QSPR studies. Theory and Application. https://doi.org/10.1590/S0103-50532009000400021
   Google Scholar
• Kumari, R., Kumar, R., & Lynn, A. (2014). G-mmpbsa -A GROMACS tool for high-throughput MM-PBSA calculations. Journal of Chemical Information and Modeling, 54(7), 1951–1962. https://doi.org/10.1021/ci500020m
   PubMed Web of Science ®Google Scholar
• Lagadec, C., Vlashi, E., Della Donna, L., Meng, Y. H., Dekmezian, C., Kim, K., & Pajonk, F. (2010). Survival and self-renewing capacity of breast cancer initiating cells during fractionated radiation treatment. Breast Cancer Research, 12(1), 13. https://doi.org/10.1186/bcr2479
   Web of Science ®Google Scholar
• Lapenna, S., & Giordano, A. (2009). Cell cycle kinases as therapeutic targets for cancer. Nature Reviews. Drug Discovery, 8(7), 547–566. https://doi.org/10.1038/nrd2907
   PubMed Web of Science ®Google Scholar
• Lee, C., Yang, W., & Parr, R. G. (1988). Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density. Physical Review. B, Condensed Matter, 37(2), 785–789. https://doi.org/10.1103/PHYSREVB.37.785
   PubMed Web of Science ®Google Scholar
• Leeson, P. D., & Davis, A. M. (2004). Time-related differences in the physical property profiles of oral drugs. Journal of Medicinal Chemistry, 47(25), 6338–6348. https://doi.org/10.1021/jm049717d
   PubMed Web of Science ®Google Scholar
• Leeson, P. D., & Springthorpe, B. (2007). The influence of drug-like concepts on decision-making in medicinal chemistry. Nature Reviews. Drug Discovery, 6(11), 881–890. https://doi.org/10.1038/nrd2445
   PubMed Web of Science ®Google Scholar
• Leoni, A., Locatelli, A., Morigi, R., & Rambaldi, M. (2014). Novel thiazole derivatives: A patent review (2008-2012; Part 1). Expert Opinion on Therapeutic Patents, 24(2), 201–216. https://doi.org/10.1517/13543776.2014.858121
   PubMed Web of Science ®Google Scholar
• Lim, S., & Kaldis, P. (2013). Cdks, cyclins and CKIs: Roles beyond cell cycle regulation. Development (Cambridge, England), 140(15), 3079–3093. https://doi.org/10.1242/dev.091744
   PubMed Web of Science ®Google Scholar
• Lindahl, E., Bjelkmar, P., Larsson, P., Cuendet, M. A., & Hess, B. (2010). Implementation of the charmm force field in GROMACS: Analysis of protein stability effects from correction maps, virtual interaction sites, and water models. Journal of Chemical Theory and Computation, 6(2), 459–466. https://doi.org/10.1021/ct900549r
   PubMed Web of Science ®Google Scholar
• Lipinski, C. A. (2004). Lead- and drug-like compounds: The rule-of-five revolution, Drug. Drug Discovery Today. Technologies, 1(4), 337–341. https://doi.org/10.1016/j.ddtec.2004.11.007
   PubMedGoogle Scholar
• Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2012). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews, 64, 4–17. https://doi.org/10.1016/j.addr.2012.09.019
   Web of Science ®Google Scholar
• Llovet, J. M., Kelley, R. K., Villanueva, A., Singal, A. G., Pikarsky, E., Roayaie, S., Lencioni, R., Koike, K., Zucman-Rossi, J., & Finn, R. S. (2021). Hepatocellular carcinoma. Nature Reviews Disease Primers, 7. https://doi.org/10.1038/s41572-020-00240-3
   PubMed Web of Science ®Google Scholar
• Lovering, F., Bikker, J., & Humblet, C. (2009). Escape from flatland: Increasing saturation as an approach to improving clinical success. Journal of Medicinal Chemistry, 52(21), 6752–6756. https://doi.org/10.1021/jm901241e
   PubMed Web of Science ®Google Scholar
• Luk, K. C., Simcox, M. E., Schutt, A., Rowan, K., Thompson, T., Chen, Y., Kammlott, U., DePinto, W., Dunten, P., & Dermatakis, A. (2004). A new series of potent oxindole inhibitors of CDK2. Bioorganic & Medicinal Chemistry Letters, 14(4), 913–917. https://doi.org/10.1016/j.bmcl.2003.12.009
   PubMed Web of Science ®Google Scholar
• Malumbres, M., & Barbacid, M. (2005). Mammalian cyclin-dependent kinases. Trends in Biochemical Sciences, 30(11), 630–641. https://doi.org/10.1016/j.tibs.2005.09.005
   PubMed Web of Science ®Google Scholar
• MarvinSketch. (2020). Chem Axon 2020. https://chemaxon.com.
   Google Scholar
• Maurer, T. S., Smith, D., Beaumont, K., & Di, L. (2020). Dose predictions for drug design. Journal of Medicinal Chemistry, 63(12), 6423–6435. https://doi.org/10.1021/acs.jmedchem.9b01365
   PubMed Web of Science ®Google Scholar
• McCubrey, J. A., Steelman, L. S., Abrams, S. L., Chappell, W. H., Russo, S., Ove, R., Milella, M., Tafuri, A., Lunghi, P., Bonati, A., Stivala, F., Nicoletti, F., Libra, M., Martelli, A. M., Montalto, G., & Cervello, M. (2009). Emerging Raf inhibitors. Expert Opinion on Emerging Drugs, 14(4), 633–648. https://doi.org/10.1517/14728210903232633
   PubMed Web of Science ®Google Scholar
• Meanwell, N. A. (2011). Improving drug candidates by design: A focus on physicochemical properties as a means of improving compound disposition and safety. Chemical Research in Toxicology, 24(9), 1420–1456. https://doi.org/10.1021/tx200211v
   PubMed Web of Science ®Google Scholar
• Morgans, A. K., Van Bommel, A. C. M., Stowell, C., Abrahm, J. L., Basch, E., Bekelman, J. E., Berry, D. L., Bossi, A., Davis, I. D., De Reijke, T. M., Denis, L. J., Evans, S. M., Fleshner, N. E., George, D. J., Kiefert, J., Lin, D. W., Matthew, A. G., McDermott, R., Payne, H., … Penson, D. F. (2015). Development of a standardized set of patient-centered outcomes for advanced prostate cancer: An international effort for a unified approach. European Urology, 68(5), 891–898. https://doi.org/10.1016/j.eururo.2015.06.007
   PubMed Web of Science ®Google Scholar
• Morigi, R., Locatelli, A., Leoni, A., & Rambaldi, M. (2015). Recent patents on thiazole derivatives endowed with antitumor activity, recent pat. Recent Patents on anti-Cancer Drug Discovery, 10(3), 280–297. https://doi.org/10.2174/1574892810666150708110432
   PubMed Web of Science ®Google Scholar
• Müller, K. (2014). Simple vector considerations to assess the polarity of partially fluorinated alkyl and alkoxy groups. Chimia, 68(6), 356–362. https://doi.org/10.2533/chimia.2014.356
   PubMed Web of Science ®Google Scholar
• Nair, A., Reece, K., Donoghue, M. B., Yuan, W., Rodriguez, L., Keegan, P., & Pazdur, R. (2021). FDA supplemental approval summary: Lenvatinib for the treatment of unresectable hepatocellular carcinoma. The Oncologist, 26(3), e484–e491. https://doi.org/10.1002/onco.13566
   PubMed Web of Science ®Google Scholar
• Nicolaou, K. C. (2014). Advancing the drug discovery and development process. Angewandte Chemie, 126(35), 9280–9292. https://doi.org/10.1002/ange.201404761
   Google Scholar
• Nour, H., Abchir, O., Belaidi, S., Qais, F. A., Chtita, S., & Belaaouad, S. (2021). 2D-QSAR and molecular docking studies of carbamate derivatives to discover novel potent anti-butyrylcholinesterase agents for Alzheimer’s disease treatment, Bull. Korean Chemical Society. https://doi.org/10.1002/BKCS.12449
   PubMed Web of Science ®Google Scholar
• Ouassaf, M., Belaidi, S., Khamouli, S., Belaidi, H., & Chtita, S. (2021). Combined 3D-QSAR and molecular docking analysis of thienopyrimidine derivatives as Staphylococcus aureus inhibitors. Acta Chimica Slovenica, 68(2), 289–303. https://doi.org/10.17344/acsi.2020.5985
   PubMed Web of Science ®Google Scholar
• Ouyang, B., Knauf, J. A., Smith, E. P., Zhang, L., Ramsey, T., Yusuff, N., Batt, D., & Fagin, J. A. (2006). Inhibitors of Raf kinase activity block growth of thyroid cancer cells with RET/PTC or BRAF mutations in vitro and in vivo. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 12(6), 1785–1793. https://doi.org/10.1158/1078-0432.CCR-05-1729
   PubMed Web of Science ®Google Scholar
• Păunescu, E., Clavel, C. M., Nowak-Sliwinska, P., Griffioen, A. W., & Dyson, P. J. (2015). Improved angiostatic activity of dasatinib by modulation with hydrophobic chains, ACS. ACS Medicinal Chemistry Letters, 6(3), 313–317. https://doi.org/10.1021/ml500496u
   PubMed Web of Science ®Google Scholar
• Petrick, J. L., Florio, A. A., Znaor, A., Ruggieri, D., Laversanne, M., Alvarez, C. S., Ferlay, J., Valery, P. C., Bray, F., & McGlynn, K. A. (2020). International trends in hepatocellular carcinoma incidence, 1978–2012. International Journal of Cancer, 147(2), 317–330. https://doi.org/10.1002/ijc.32723
   PubMed Web of Science ®Google Scholar
• Pine, S. R., Ryan, B. M., Varticovski, L., Robles, A. I., & Harris, C. C. (2010). Microenvironmental modulation of asymmetric cell division in human lung cancer cells. Proceedings of the National Academy of Sciences of the United States of America, 107(5), 2195–2200. https://doi.org/10.1073/pnas.0909390107
   PubMed Web of Science ®Google Scholar
• Pires, D. E. V., Blundell, T. L., & Ascher, D. B. (2015). Ascher, pkCSM: Predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. Journal of Medicinal Chemistry, 58(9), 4066–4072. https://doi.org/10.1021/acs.jmedchem.5b00104
   PubMed Web of Science ®Google Scholar
• Popsavin, M., Kojić, V., Spaić, S., Svirčev, M., Bogdanović, G., Jakimov, D., Aleksić, L., & Popsavin, V. (2014). 2-Substituted thiazole-4-carboxamide derivatives as tiazofurin mimics: Synthesis and in vitro antitumour activity. Tetrahedron, 70(14), 2343–2350. https://doi.org/10.1016/j.tet.2014.02.035
   Web of Science ®Google Scholar
• Ritchie, T. J., & Macdonald, S. J. F. (2009). The impact of aromatic ring count on compound developability – are too many aromatic rings a liability in drug design? Drug Discovery Today, 14(21–22), 1011–1020. https://doi.org/10.1016/j.drudis.2009.07.014
   PubMed Web of Science ®Google Scholar
• Ritchie, T. J., Macdonald, S. J. F., Young, R. J., & Pickett, S. D. (2011). The impact of aromatic ring count on compound developability: Further insights by examining carbo- and hetero-aromatic and -aliphatic ring types. Drug Discovery Today, 16(3–4), 164–171. https://doi.org/10.1016/j.drudis.2010.11.014
   PubMed Web of Science ®Google Scholar
• Rouf, A., & Tanyeli, C. (2015). Bioactive thiazole and benzothiazole derivatives. European Journal of Medicinal Chemistry, 97, 911–927. https://doi.org/10.1016/j.ejmech.2014.10.058
   PubMed Web of Science ®Google Scholar
• Roy, K., Kar, S., & Ambure, P. (2015). On a simple approach for determining applicability domain of QSAR models. Chemometrics and Intelligent Laborary Systems. 145, 22–29. https://doi.org/10.1016/j.chemolab.2015.04.013
   Web of Science ®Google Scholar
• Schiebel, J., Gaspari, R., Wulsdorf, T., Ngo, K., Sohn, C., Schrader, T. E., Cavalli, A., Ostermann, A., Heine, A., & Klebe, G. (2018). Intriguing role of water in protein-ligand binding studied by neutron crystallography on trypsin complexes. Nature Communications, 9(1) https://doi.org/10.1038/s41467-018-05769-2
   PubMedGoogle Scholar
• Serajuddin, A., Pudipeddi, M., & Stahl, P. (2002). Handbook of pharmaceutical salts. 376.
   Google Scholar
• Sharma, J., Kumar Bhardwaj, V., Singh, R., Rajendran, V., Purohit, R., & Kumar, S. (2021). An in-silico evaluation of different bioactive molecules of tea for their inhibition potency against non structural protein-15 of SARS-CoV-2. Food Chemistry, 346, 128933. https://doi.org/10.1016/j.foodchem.2020.128933
   PubMed Web of Science ®Google Scholar
• Shen, S., Dean, D. C., Yu, Z., & Duan, Z. (2019). Role of cyclin-dependent kinases (CDKs) in hepatocellular carcinoma: Therapeutic potential of targeting the CDK signaling pathway. Hepatology Research : The Official Journal of the Japan Society of Hepatology, 49(10), 1097–1108. https://doi.org/10.1111/hepr.13353
   PubMed Web of Science ®Google Scholar
• Siegel, R. L., Miller, K. D., & Jemal, A. (2015). Cancer statistics, 2015. CA: A Cancer Journal for Clinicians, 65(1), 5–29. https://doi.org/10.3322/caac.21254
   PubMed Web of Science ®Google Scholar
• Siegel, R., Naishadham, D., & Jemal, A. (2013). Cancer statistics, 2013. CA: A Cancer Journal for Clinicians, 63(1), 11–30. https://doi.org/10.3322/caac.21166
   PubMed Web of Science ®Google Scholar
• Sittikul, P., Songtawee, N., Kongkathip, N., & Boonyalai, N. (2018). In vitro and in silico studies of naphthoquinones and peptidomimetics toward Plasmodium falciparum plasmepsin V. Biochimie, 152, 159–173. https://doi.org/10.1016/j.biochi.2018.07.002
   PubMed Web of Science ®Google Scholar
• Speciale, A., Muscarà, C., Molonia, M. S., Cimino, F., Saija, A., & Giofrè, S. V. (2021). Silibinin as potential tool against SARS-Cov-2: In silico spike receptor-binding domain and main protease molecular docking analysis, and in vitro endothelial protective effects. Phytotherapy Research : PTR, 35(8), 4616–4625. https://doi.org/10.1002/ptr.7107
   PubMed Web of Science ®Google Scholar
• Netzeva, T. I., Worth, A. P., Aldenberg, T., Benigni, R., Cronin, M. T. D., Gramatica, P., Jaworska, J. S., Kahn, S., Klopman, G., Marchant, C. A., Myatt, G., Nikolova-Jeliazkova, N., Patlewicz, G. Y., Perkins, R., Roberts, D. W., Schultz, T., Stanton, D. W., Van De Sandt, J. J. M., Tong, W., Veith, G., & Yang, C. (2005). Current status of methods for defining the applicability domain of (quantitative) structure-activity relationships, ATLA. Alternatives to Laboratory Animals : ATLA, 33(2), 155–173. https://doi.org/10.1177/026119290503300209
   PubMed Web of Science ®Google Scholar
• Tabti, K., Elmchichi, L., Sbai, A., Maghat, H., Bouachrine, M., Lakhlifi, T., & Ghosh, A. (2022). In silico design of novel PIN1 inhibitors by combined of 3D-QSAR, molecular docking, molecular dynamic simulation and ADMET studies. Journal of Molecular Structure. 1253, 132291. https://doi.org/10.1016/j.molstruc.2021.132291
   Web of Science ®Google Scholar
• Tong, J., Zhang, X., Luo, D., & Bian, S. (2021). Molecular design, molecular docking and ADMET study of cyclic sulfonamide derivatives as SARS-CoV-2 inhibitors. Chinese Journal of Analytical Chemistry, 49(12), 63–73. https://doi.org/10.1016/j.cjac.2021.09.006
   Web of Science ®Google Scholar
• Veber, D. F., Johnson, S. R., Cheng, H. Y., Smith, B. R., Ward, K. W., & Kopple, K. D. (2002). Molecular properties that influence the oral bioavailability of drug candidates. Journal of Medicinal Chemistry, 45(12), 2615–2623. https://doi.org/10.1021/jm020017n
   PubMed Web of Science ®Google Scholar
• Veerasamy, R., Rajak, H., Jain, A., Sivadasan, S., Varghese, C. P., & Agrawal, R. K. (2011). Validation of QSAR Models - Strategies and Importance. International Journal of Drug Design & Discovery, 2, 511–519.
   Google Scholar
• Vilar, S., Cozza, G., & Moro, S. (2008). Medicinal chemistry and the molecular operating environment (MOE): Application of QSAR and molecular docking to drug discovery. Current Topics in Medicinal Chemistry, 8(18), 1555–1572. https://doi.org/10.2174/156802608786786624
   PubMed Web of Science ®Google Scholar
• Wager, T. T., Kormos, B. L., Brady, J. T., Will, Y., Aleo, M. D., Stedman, D. B., Kuhn, M., & Chandrasekaran, R. Y. (2013). Improving the odds of success in drug discovery: Choosing the best compounds for in vivo toxicology studies. Journal of Medicinal Chemistry, 56(23), 9771–9779. https://doi.org/10.1021/jm401485p
   PubMed Web of Science ®Google Scholar
• Wold, S., Eriksson, L., & Clementi, S. (2008). Statistical Validation of QSAR Results. Chemometric Methods in Molecular Design, 2, 309–338. https://doi.org/10.1002/9783527615452.ch5
   Google Scholar
• XLSTAT version 2019.1, XLSTAT. (n.d). Your data analysis solution. https://www.xlstat.com/fr/articles/xlstat-version-2019-1.
   Google Scholar
• Young, R. J., Green, D. V. S., Luscombe, C. N., & Hill, A. P. (2011). Getting physical in drug discovery II: The impact of chromatographic hydrophobicity measurements and aromaticity. Drug Discovery Today, 16(17–18), 822–830. https://doi.org/10.1016/j.drudis.2011.06.001
   PubMed Web of Science ®Google Scholar
• Zanger, U. M., & Schwab, M. (2013). Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacology & Therapeutics, 138(1), 103–141. https://doi.org/10.1016/j.pharmthera.2012.12.007
   PubMed Web of Science ®Google Scholar